all AI news
Merck enters Two Strategic Collaborations
AI – AI-TechPark ai-techpark.com
Partnerships with BenevolentAI and Exscientia to drive accelerated drug discovery with higher probability of success Access to end-to-end AI platform capabilities to generate novel development candidates in oncology, neurology and immunology AI-powered R&D integral part of delivering on ambition of bringing more medicines to more patients, faster Merck, a leading...
The post Merck enters Two Strategic Collaborations first appeared on AI-TechPark.
ai ai platform ai-powered capabilities development discovery drive drug discovery end-to-end ai faster generate immunology integral medicines neurology novel oncology part partnerships patients platform probability success